
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Diffuse esophageal spasmmedical therapy
Introduction
Overview
Overview
The mainstay of treatment for DES is medical therapy with calcium channel blockers, and/or tricyclic antidepressants.
Medical Therapy
Medical Therapy
- Patients with are treated with calcium channel blockers if dysphagia is predominant , whereas patients with predominant chest pain are treated with either calcium channel blockers or tricyclic antidepressants.
- Nitrate releasing drugs and local injection of botox toxin are used if above measures fail.
- Proton pump inhibitors are used in secondary DES.
Diffuse esophageal spasm
- 1 Primary DES
- 1.1 Adult
- Preferred regimen (1): diltiazem 180-240 mg PO q24h for 7-10 days. (Contraindications: Hypersensitivity, AV block (2nd or 3rd degree), hypotension, acute MI)
- Preferred regimen (2): imipramine 25-50 mg at bedtime for 14-21 days.
- Alternative regimen (2):Isosorbide 10 mg or sildenafil 50 mg PO as needed.
- 1.2 Pediatric
- Preferred regimen (1): diltiazem 1.5-2mg/kg 50 mg/kg PO in 3-4 divided doses.
- Preferred regimen (2): imipramine 10-25 mg PO per day at bedtime. (maximum, 50mg/day if 6 years to < 12 years and 75mg/day if = or > 12 years).
- 1.1 Adult
- 2 Secondary DES (treatment of GERD)
- 2.1 Adult
- Preferred regimen (1): omeprazole 20mg PO q24h for 4 weeks
- 2.2 Pediatric for =<1 year and >= 16yrs
- Preferred regimen (1): 5kg to <10 kg; omeprazole 5mg PO q24h for 4 weeks
- 10kg to ,20 kg; omeprazole 10mg PO q24h for 4 weeks
- >= 20 kg; omeprazole 20mg PO q24h for 4 weeks.
- 2.1 Adult
- Refractory cases
- Cases refractory to above treatment,endoscopic injection of Botulinum toxin 100U is the next medical therapy.
References
References
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Madhu Sigdel M.B.B.S.[2]
